| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/29/2008 | US7365154 Use as an immunogen to generate anti-integrin antibodies; a mimotope; vaccinating against angiogenic and metastatic diseases |
| 04/29/2008 | US7365054 Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies |
| 04/29/2008 | US7364887 Osteoarthritis; rheumatic diseases; antiarthritic agents |
| 04/29/2008 | US7364878 Improving gene expression in host cells vial use of vector comprising stabilizing anti-repressor (STAR) sequences; enhancer elements |
| 04/29/2008 | US7364867 Nucleotide sequences which code a membrane protein for use in flavor intensification of in food, beverages or pharmaceuticals |
| 04/29/2008 | US7364865 Antibodies to myeloid progenitor inhibitory factor-1 (MPIF-1) |
| 04/29/2008 | US7364864 ANGE gene in atopy |
| 04/29/2008 | US7364863 Monoclonal antibody for use in classification and identification of embryonic connective tissue progenitor cells; regenerative medicine |
| 04/29/2008 | US7364860 Diagnosing hepatitis c infection using genetically engineered lymphadenopathy associated viral protein |
| 04/29/2008 | US7364859 Methods of using bioelastomers |
| 04/29/2008 | US7364845 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cancer, psoriasis and nervous system disorders |
| 04/29/2008 | US7364744 Synthetic peptide vaccines for HIV: the CBD epitope as an effective immunogen to elicit broadly neutralizing antibodies against HIV |
| 04/29/2008 | US7364742 Respiratory syncytial virus antibody comprising at least one heavy chain variable region and at least one light chain variable region having specific amino acid sequences; encoding complementary nucleic acids, vectors, host cells, transgenic animals or plants |
| 04/29/2008 | US7364741 Peptides of human Papilloma virus for use in human T cell response inducing compositions |
| 04/29/2008 | US7364739 Haemophilus influenzae lipopolysaccharide inner-core oligosaccharide epitopes as vaccines for the prevention of Haemophilus influenzae infections |
| 04/29/2008 | US7364738 Monoclonal antibodies to the CLFA protein and method of use in treating infections |
| 04/29/2008 | US7364737 Binding, neutralization respiratory syncytial virus antigen |
| 04/29/2008 | US7364736 Immmunoglobulin which prevents binding of osteoprotegerin ligand (OPGL) to osteoclast differentiation and activation receptor (ODAR) for treatment and prevention of bone, inflammatory, arthritic and autoimmune disorders |
| 04/29/2008 | US7364735 Method for diagnosis and treatment of haemophilia A patients with an inhibitor |
| 04/29/2008 | US7364734 Treatment of LFA-1 associated disorders with increasing doses of LFA-1 antagonist |
| 04/29/2008 | US7364733 antibodies that bind to Activated CD4+ T-cells (ACT-4) receptors; diagnostic or therapeutic use for immune disorders; selective suppression of immune response; allograft rejection, graft versus host disease, autoimmune diseases, allergies |
| 04/29/2008 | US7364732 Method for treating inflammation |
| 04/29/2008 | US7364731 Polypeptide variants |
| 04/29/2008 | US7364730 Human K+ channel and prognosing applications thereof |
| 04/29/2008 | CA2370098C Human beta-trcp protein |
| 04/29/2008 | CA2285136C Coccidiosis vaccines |
| 04/24/2008 | WO2008049106A2 Process for preparing unaggregated antibody fc domains |
| 04/24/2008 | WO2008049098A2 ANTIBODY ANTAGONISTS OF INTERLEUKIN-13 RECEPTOR α1 |
| 04/24/2008 | WO2008048689A2 Methods for the treatment of muscular dystrophy associated with dysferlin-deficiency |
| 04/24/2008 | WO2008048670A2 Compositions and methods for modulating tlr14 activity |
| 04/24/2008 | WO2008048345A2 Detection systems for mass labels |
| 04/24/2008 | WO2008047925A1 Pharmaceutical composition comprising anti-hb-egf antibody as active ingredient |
| 04/24/2008 | WO2008047914A1 Cancer therapeutic agent comprising anti-hb-egf antibody as active ingredient |
| 04/24/2008 | WO2008047723A1 Diagnosis and treatment of cancer using anti-ereg antibody |
| 04/24/2008 | WO2008047480A1 Method for control of distribution of mutation sites in variable region of antibody gene |
| 04/24/2008 | WO2008047242A2 Novel anti-cd38 antibodies for the treatment of cancer |
| 04/24/2008 | WO2008047134A2 Antibody molecules which bind il-17a and il-17f |
| 04/24/2008 | WO2008046724A1 Method for generating active antibodies against a resistance antigen, antibodies obtained by said method and their uses |
| 04/24/2008 | WO2008021263A3 Methods of indentifying antibodies that bind oligomeric forms of chemokines and uses thereof |
| 04/24/2008 | WO2008016629A3 Novel glutamic acid decarboxylase (gad) proteins and methods of use |
| 04/24/2008 | WO2008006554A3 Glyco-engineered antibodies |
| 04/24/2008 | WO2008003116A3 Method for engineering immunoglobulins |
| 04/24/2008 | WO2007149935A3 Methods and compositions for modulating hepsin activation of urokinase-type plasminogen activator |
| 04/24/2008 | WO2007143168A3 High affinity antibodies to human il-6 receptor |
| 04/24/2008 | WO2007084926A3 Compositions and methods for humanization and optimization of n-glycans in plants |
| 04/24/2008 | US20080098490 Recombinant animal for use as bioreactor in production of human immunoglobulins |
| 04/24/2008 | US20080097081 BH3 interacting domain death agonist for use in prevention ans treatment of apoptosis associated disorders |
| 04/24/2008 | US20080096981 modulating activities associated with the IL-9 pathway for the treatment of atopic allergies like asthma; autoimmune diseases; new genes tightly expressed in association with an inflammatory response in the airways mediated by type 2 helper T-cells (TH). These genes have been designated TH2AF1 |
| 04/24/2008 | US20080096833 Diagnostic drugs and kits; coded for human proto-oncogene Pim-3, an antibody specific thereto; short interence RNA; genetic engineering |
| 04/24/2008 | US20080096821 Cytostatin II |
| 04/24/2008 | US20080096818 administering polypeptides comprising beta amyloid fragments, to induce immunogenic response against amyloid deposits; prophylaxios and therapy of Alzheimer's disease |
| 04/24/2008 | US20080096810 Cab Molecules |
| 04/24/2008 | US20080096806 Compositions and methods for inhibiting microbial adhesion |
| 04/24/2008 | US20080096796 Peptides That Stimulate Cell Survival and Axon Regeneration |
| 04/24/2008 | US20080096795 Novel Antiangiogenic Peptide Agents and Their Therapeutic and Diagnostic Use |
| 04/24/2008 | US20080096794 proteins used for the prevention and/or treatment of tumors, development disorders, autoimmune diseases,allergies and inflammations; foods or nutraceuticals |
| 04/24/2008 | US20080096792 polypeptides used as wound healing agents, tissue regeneration, inhibition of cancer metastesis mediated by extracellular matrix protein including laminin |
| 04/24/2008 | US20080096263 Recombinant Parainfluenza Virus Expression Systems And Vaccines Comprising Heterologous Antigens Derived From Respiratory Syncytial Virus |
| 04/24/2008 | US20080096250 Expression vector comprising nucleotide sequences coding inflammatory response polypeptide for use in treatment and prevention of inflammation |
| 04/24/2008 | US20080096237 Using immunoglobulin specific to H11 kinase mutant as evaluative tool in detection and diagnosis of cell proliferative disorders |
| 04/24/2008 | US20080096236 Method for Detecting the Presence of Target Bacteria or a Target Component Carbohydrate Antigen Thereof |
| 04/24/2008 | US20080096229 Filamentous receptor structure comprising D3 domain for use as components of elements |
| 04/24/2008 | US20080096222 Compositions And Methods Based Upon The Kinase Haspin |
| 04/24/2008 | US20080096187 Molecular Scaffolds for HIV-1 Epitopes |
| 04/24/2008 | US20080095805 Method Of Detecting Cancer Based On Immune Reaction To Boris |
| 04/24/2008 | US20080095793 Expression vector comprising nucleotide sequences coding protein fusion for use in treatment and prevention of microorganismal infection |
| 04/24/2008 | US20080095785 Monoclonal antibodies to human high molecular weight-melanoma associated antigen |
| 04/24/2008 | US20080095784 Monospecific immunoglobulin for treating autoimmune, cell proliferative and transplant rejection disorders |
| 04/24/2008 | US20080095783 Monoclonal antibody specific to Lewis Y antigen for enhancing antibody dependent cell-mediated cytotoxicity and treatment of cell proliferative disorders; immunotherapy; tissue targeted therapy |
| 04/24/2008 | US20080095781 Agonist antibody specific for death receptor-4 (DR4)polypeptide for use in treatment and prevention of infection, nervous system, cell proliferative and autoimmune disorders |
| 04/24/2008 | US20080095780 Binding Molecules For Treatment And Detection Of Cancer |
| 04/24/2008 | US20080095779 Using modulators which alter protein DNA binding as tool in prevention and treatment of cell proliferative disorders |
| 04/24/2008 | US20080095778 Treatment Of Fungal Infections |
| 04/24/2008 | US20080095776 Erythropoietin receptor binding antibodies |
| 04/24/2008 | US20080095775 Immunoglobulin for use in prevention and treatment of diabetes, arthritis, autoimmune, skin, respiratory and inflammatory disorders; immunotherapy |
| 04/24/2008 | US20080095774 Agents and Methods for Specifically Blocking CD28-Mediated Signaling |
| 04/24/2008 | US20080095773 Polypeptides homologous to vegf and bmp1 |
| 04/24/2008 | US20080095772 Antibodies against human parathyroid hormone related protein |
| 04/24/2008 | US20080095769 Monoclonal antibody secific to lymphocyte peripheral membrane protein for treating and preventing transplant rejection, blood, skin, autoimmune, allergic and diabetic disorders |
| 04/24/2008 | US20080095767 Engineered antibodies with new world primate framework regions |
| 04/24/2008 | US20080095765 IL-5R-specific antibody composition |
| 04/24/2008 | US20080095762 Glycoprotein compositions |
| 04/24/2008 | US20080095761 Using steroid alkaloid cyclopamine to treat and prevent tumor progression in urogenital system |
| 04/24/2008 | US20080095758 Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damage |
| 04/24/2008 | US20080095747 Promotion of Cell Migration and Axon Regeneration in the Cns |
| 04/24/2008 | US20080095700 DR4 antibodies and uses thereof |
| 04/24/2008 | CA2667636A1 Ssl7 mutants and uses therefor |
| 04/24/2008 | CA2666842A1 Il-17c antagonists and methods of using the same |
| 04/24/2008 | CA2666809A1 Anti-cancer agent comprising anti-hb-egf antibody as active ingredient |
| 04/24/2008 | CA2666559A1 Pharmaceutical composition comprising anti-hb-egf antibody as active ingredient |
| 04/24/2008 | CA2666507A1 Synthetic antibodies |
| 04/24/2008 | CA2666458A1 Antibody molecules which bind il-17a and il-17f |
| 04/24/2008 | CA2665826A1 Molecules with reduced half-lives, compositions and uses thereof |
| 04/24/2008 | CA2665592A1 Compositions and methods for modulating tlr14 activity |
| 04/24/2008 | CA2665534A1 Antibodies that bind cxcr7 epitopes |
| 04/24/2008 | CA2665528A1 Diagnosis and treatment of cancer using anti-ereg antibody |
| 04/24/2008 | CA2663561A1 Method for generating active antibodies against a resistance antigen, antibodies obtained by said method and their uses |
| 04/24/2008 | CA2663209A1 Novel anti-cd38 antibodies for the treatment of cancer |
| 04/23/2008 | EP1914554A2 Diagnostic assay and method of treatment involving macrophage inhibitory cytokine-1 (MIC-1) |
| 04/23/2008 | EP1914319A2 Polymorphisms and new genes in the region of the human hemochromatosis gene |